Fatal Human H3N8 Influenza Virus has a Moderate Pandemic Risk
Le Sage, V.; Vu, M. N.; Maltepes, M. A.; Wang, S.; Snow, B. A.; Merrbach, G. A.; Benton, A. J.; Zirckel, K. E.; Petnuch, S. E.; Marble, C. N.; Rigatti, L. H.; Paulson, J. C.; Drapeau, E. M.; McElroy, A. K.; Hensley, S. E.; Moncla, L. H.; Lakdawala, S.
Show abstract
In China, low pathogenic avian influenza (LPAI) H3N8 virus is widespread among chickens and has recently caused three zoonotic infections, with the last one in 2023 being fatal. Here we evaluated the relative pandemic risk of this 2023 zoonotic H3N8 influenza virus, utilizing our previously published decision tree. Serological analysis indicated that a large proportion of the human population does not have any cross-neutralizing antibodies against this H3N8 strain. LPAI H3N8 displayed a dual affinity for 2-3 and 2-6 sialic acids and replicated efficiently in human bronchial epithelial cells. Furthermore, we observed H3N8 transmission via direct contact but not aerosols to ferrets with pre-existing H3N2 immunity. Although pre-existing H3N2 immunity resulted in a shortened disease course in ferrets, it did not reduce disease severity or replication in the respiratory tract. This study suggests that this zoonotic H3N8 strain has moderate pandemic potential and emphasizes the continued need for avian influenza surveillance.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.